Metacrine Competitors and Similar CompaniesClear all
Metacrine's competitors and similar companies include Aligos Therapeutics, Fulcrum Therapeutics, Xenotherapeutics Inc and Themis Bioscience.
 Aligos Therapeutics Aligos Therapeutics is a company that develops curative therapies for hepatologic diseases and viral infections. |  Fulcrum Therapeutics We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are. |  Xenotherapeutics Inc Xenotherapeutics serves transplantable cells and enable therapies to treat common and rare diseases. | |||
Founding Date | Founding Date 2015 | Founding Date 2018 | Founding Date 2016 | Founding Date 2016 | Founding Date 2009 |
Type | Type Private | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations San Diego, US HQ San Diego, US San Diego, US | Locations South San Francisco, US HQ Leuven, BE | Locations Cambridge, US HQ | Locations Boston, US HQ | Locations Wien, AT HQ |
Employees | Employees 4 | Employees 706% increase | Employees 43223% increase | Employees 11 | Employees 373% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 28.8 m | Valuation ($) 202.2 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($24.2m) (FY, 2025) | Net income ($74.9m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 123m | Total funding raised $ 225m | Total funding raised $ 55m | Total funding raised N/A | Total funding raised $ 81.8m |
For sources of this data, please see the company profile
View Company Profiles
Aligos Therapeutics
HQ
South San Francisco, US
Employees
70↑ 6% increase
Aligos Therapeutics is a company that develops curative therapies for hepatologic diseases and viral infections.
View companyFulcrum Therapeutics
HQ
Cambridge, US
Employees
432↑ 23% increase
We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.
View companyXenotherapeutics Inc
HQ
Boston, US
Employees
11
Xenotherapeutics serves transplantable cells and enable therapies to treat common and rare diseases.
View company
Themis Bioscience
HQ
Wien, AT
Themis Bioscience develops vaccines against tropical infections.
View company